IMPROVEMENTS IN QUALITY OF LIFE IN BEHCET'S SYNDROME PATIENTS TREATED WITH APREMILAST: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：0
|
作者：
Hatemi, Gulen [1 ]
Mahr, Alfred [2 ]
Takeno, Mitsuhiro [3 ]
Kim, Doyoung [4 ]
Melikoglu, Melike [5 ]
Cheng, Sue [6 ]
Mccue, Shannon [6 ]
Paris, Maria [6 ]
Chen, Mindy [6 ]
Yazici, Yusuf [7 ]
机构：
[1] Istanbul Univ Cerrahpasa, Med, Istanbul, Turkey
[2] St Louis Hosp, Paris, France
[3] Nippon Med Sch, Bunkyo Ku, Tokyo, Japan
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Istanbul Univ Cerrahpasa, Istanbul, Turkey
[6] Celgene Corp, Summit, NJ USA
[7] NYU, Sch Med, New York, NY USA
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
250
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clonidine premedication in patients with sleep apnea syndrome: A randomized, double-blind, placebo-controlled study
    Pawlik, MT
    Hansen, E
    Waldhauser, D
    Selig, C
    Kuehnel, TS
    ANESTHESIA AND ANALGESIA, 2005, 101 (05): : 1374 - 1380
  • [42] Acarbose in obese patients with polycystic ovarian syndrome:: a double-blind, randomized, placebo-controlled study
    Penna, IAA
    Canella, PRB
    Reis, RM
    Silva de Sá, MF
    Ferriani, RA
    HUMAN REPRODUCTION, 2005, 20 (09) : 2396 - 2401
  • [43] QUALITY OF LIFE IN PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL STUDY OF JZP-258 IN ADULTS WITH NARCOLEPSY WITH CATAPLEXY
    Foldvary-Schaefer, N.
    Thorpy, M. J.
    Dauvilliers, Y.
    Roy, A.
    Tang, L.
    Skowronski, R.
    Sonka, K.
    Bogan, R. K.
    SLEEP, 2020, 43 : A281 - A282
  • [44] A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca
    Petrone, D
    Condemi, JJ
    Fife, R
    Gluck, O
    Cohen, S
    Dalgin, P
    ARTHRITIS AND RHEUMATISM, 2002, 46 (03): : 748 - 754
  • [45] Quality of Life in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of JZP-258 in Adults with Narcolepsy with Cataplexy
    Foldvary-Schaefer, Nancy
    Thorpy, Michael J.
    Dauvilliers, Yves
    Roy, Asim
    Tang, Lihua
    Skowronski, Roman
    Sonka, Karel
    Bogan, Richard K.
    ANNALS OF NEUROLOGY, 2020, 88 : S254 - S255
  • [46] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [47] Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Krause, K.
    Weller, K.
    Metz, M.
    Magerl, M.
    Martus, P.
    Church, M. K.
    Maurer, M.
    ALLERGY, 2013, 68 (07) : 949 - 952
  • [48] Quality of life of mild hypertension treated with captopril-A randomized, double-blind, placebo-controlled clinical trial
    YuHu
    Zhu, JR
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 161 - 161
  • [49] REGENERATE: A Global Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of OCA for NASH
    Ratziu, Vlad
    Sanyal, Arun J.
    MacConell, Leigh
    Herrmann, Sibylle
    Shringarpure, Reshma
    Marmon, Tonya
    Shapiro, David
    Younossi, Zobair M.
    SWISS MEDICAL WEEKLY, 2016, 146 : 17S - 17S
  • [50] Rupatadine treatment improves quality of life in patients with mastocytosis: a randomized, double-blind, placebo-controlled trial
    Siebenhaar, F.
    Foertsch, A.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E12 - E12
12345